JPS6345371B2 - - Google Patents
Info
- Publication number
- JPS6345371B2 JPS6345371B2 JP1073780A JP1073780A JPS6345371B2 JP S6345371 B2 JPS6345371 B2 JP S6345371B2 JP 1073780 A JP1073780 A JP 1073780A JP 1073780 A JP1073780 A JP 1073780A JP S6345371 B2 JPS6345371 B2 JP S6345371B2
- Authority
- JP
- Japan
- Prior art keywords
- lecithin
- pantethine
- lcat
- nephropathy
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1073780A JPS56108712A (en) | 1980-01-31 | 1980-01-31 | Lecithin cholesterol acyl transferase activator |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1073780A JPS56108712A (en) | 1980-01-31 | 1980-01-31 | Lecithin cholesterol acyl transferase activator |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56108712A JPS56108712A (en) | 1981-08-28 |
| JPS6345371B2 true JPS6345371B2 (show.php) | 1988-09-09 |
Family
ID=11758600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1073780A Granted JPS56108712A (en) | 1980-01-31 | 1980-01-31 | Lecithin cholesterol acyl transferase activator |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56108712A (show.php) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995034811A1 (en) * | 1993-06-11 | 1995-12-21 | Oculon Corporation | Protein condensation inhibitors and methods related thereto |
| WO2015050148A1 (ja) * | 2013-10-04 | 2015-04-09 | 第一三共株式会社 | 3-アリールピラゾロピリジン誘導体 |
| WO2015076353A1 (ja) * | 2013-11-25 | 2015-05-28 | 第一三共株式会社 | 3-アルキルピラゾロピリジン誘導体 |
-
1980
- 1980-01-31 JP JP1073780A patent/JPS56108712A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56108712A (en) | 1981-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shapiro | Warfarin Sodium Derivative:(Coumadin® Sodium) An Intravenous Hypoprothrombinemia-Inducing Agent | |
| JPH05213745A (ja) | 病態生理学的原因による刺激障害及びそれに因る病気並びにアレルギー病の治療薬及びその製法 | |
| JPS5841821A (ja) | 最少化された胃の損傷を示す抗炎症組成物 | |
| JPS61145121A (ja) | ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤 | |
| JPS62246521A (ja) | シヨツク症状及び呼吸機能障害や心臓循環機能不全を治療する為のコレシストキニン−セルレイン群のペプチツドを含有する薬学的組成物 | |
| JPS59112948A (ja) | コレステロ−ルレベル低下剤 | |
| Davidson et al. | Action and metabolism of chlorpromazine sulfoxide in man | |
| US2761807A (en) | Glycocyamine and methylating agent in vivo creatine producing composition | |
| JPS625913A (ja) | ジヒドロピリジン含有製剤 | |
| JPH08295637A (ja) | 口腔部局所投与剤 | |
| JPS6345371B2 (show.php) | ||
| MOSHER | Local use of cortisone in ophthalmic diseases | |
| RU2181286C2 (ru) | Кардиотоническое и гипертензивное средство, длительно повышающее давление, и лекарственные формы на его основе | |
| IE71022B1 (en) | Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamides containing preparation and stabilizing method therefor | |
| UA128573C2 (uk) | Способи лікування підвищення маси тіла, індукованого антипсихотичними засобами, за допомогою мірикориланту | |
| Rotmensch et al. | Furosemide-induced forced diuresis in digoxin intoxication | |
| US3914425A (en) | Antitussive codeine composition | |
| JPH05504130A (ja) | 腫瘍壊死因子拮抗剤 | |
| JPH0788300B2 (ja) | エピニンあるいはその製薬的に許容しうる塩を含む医薬組成物ならびに用途 | |
| JP2835547B2 (ja) | 糖尿病治療剤 | |
| Lemieux et al. | Treatment of arterial hypertension with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina | |
| Winsor et al. | Monoamine oxidase inhibitors and angina pectoris | |
| JPH01216923A (ja) | プロスタグランジン類の選択的作用増強剤 | |
| EP0425902A1 (en) | Use of isosorbide 2-mononitrate in the preparation of pharmaceutical compositions for treating angina pectoris | |
| JPS632926A (ja) | 安定な、注射可能な制吐性組成物 |